Abstract Retinal and choroidal vascular diseases constitute the most common causes of moderate and severe vision loss in developed countries. They can be divided into retinal vascular diseases, in which there is leakage and/or neovascularization (NV) from retinal vessels, and subretinal NV, in which new vessels grow into the normally avascular outer retina and subretinal space. The first category of diseases includes diabetic retinopathy, retinal vein occlusions, and retinopathy of prematurity, and the second category includes neovascular age-related macular degeneration (AMD), ocular histoplasmosis, pathologic myopia, and other related diseases. Retinal hypoxia is a key feature of the first category of diseases resulting in elevated levels of hypoxia-inducible factor-1 (HIF-1) which stimulates expression of vascular endothelial growth factor (VEGF), platelet-derived growth factor-B (PDGF-B), placental growth factor, stromal-derived growth factor-1 and their receptors, as well as other hypoxia-regulated gene products such as angiopoietin-2. Although hypoxia has not been demonstrated as part of the second category of diseases, HIF-1 is elevated and thus the same group of hypoxia-regulated gene products plays a role. Clinical trials have shown that VEGF antagonists provide major benefits for patients with subretinal NV due to AMD and even greater benefits are seen by combining antagonists of VEGF and PDGF-B. It is likely that addition of antagonists of other agents listed above will be tested in the future. Other appealing strategies are to directly target HIF-1 or to use gene transfer to express endogenous or engineered anti-angiogenic proteins. While substantial progress has been made, the future looks even brighter for patients with retinal and choroidal vascular diseases.
HIF-1               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hypoxia-inducible_factors

endogenous                    0.9999999999984084^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Endogeny              

neovascularization            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Neovascularization    

hypoxia                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hypoxia_(medical)     

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

age-related macular degeneration1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_degeneration  

placental                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Placenta              

NV                            0.9983876832721718^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nevada                

NV                            0.9983876832721718^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nevada                

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

proteins                      0.9999938394104128^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein               

avascular                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Blood_vessel          

retinopathy                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

hypoxia-inducible factor-1    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hypoxia-inducible_factors

AMD                           0.9999678355870962^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Advanced_Micro_Devices

HIF-1                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hypoxia-inducible_factors

HIF-1                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hypoxia-inducible_factors

retina                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

gene                          0.9961187998141308^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Gene                  

hypoxia                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hypoxia_(medical)     

VEGF                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vascular_endothelial_growth_factor

NV                            0.9983876832721718^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nevada                

gene                          0.9961187998141308^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Gene                  

gene                          0.9961187998141308^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Gene                  

AMD                           0.9999678355870962^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Advanced_Micro_Devices

ocular histoplasmosis         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Presumed_ocular_histoplasmosis_syndrome

developed countries           0.9999999988649506^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Developed_country     

vascular endothelial growth factor1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vascular_endothelial_growth_factor

anti-angiogenic               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Angiogenesis          

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

retinal                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retina                

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

myopia                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Myopia                

angiopoietin                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Angiopoietin          

VEGF                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vascular_endothelial_growth_factor

VEGF                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Vascular_endothelial_growth_factor

vision loss                   0.9999999983906491^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Vision_loss           

